Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lactobacillus plantarum ATG-K2 is a probiotic bacterial strain studied for its anti-obesity, anti-inflammatory, antimicrobial, and potential therapeutic effects in metabolic and mucosal disorders. It modulates the gut microbiome, produces lactic acid, downregulates pro-inflammatory cytokines, and regulates genes involved in lipid synthesis.
Modulation of gut/vaginal microbiota composition, Production of lactic acid leading to increased short-chain fatty acids (SCFAs), Downregulation of pro-inflammatory cytokines, Regulation of genes involved in lipid synthesis/metabolism
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lactobacillus plantarum ATG-K2 (ATG-K2).